Rheumatoid Arthritis Terminated Phase 2 Trials for Toreforant (DB12522)

Back to Rheumatoid Arthritis

Also known as: Rheumatoid Arthritis(RA) / Rheumatoid Arthritis, NOS / Rheumatoid Arthritis RA / Rhematoid Arthritis / Rheumatic Arthritis / Rheumatoid Arthritis (RA) / Arthritis, Rheumatoid / Arthritis,Rheumatoid / Arthritis, Rheumatoid (RA) / Rheumatoid Arthritis（RA） / RA / Systemic rheumatoid arthritis / Rheumatoid arthritis (disorder) / Arthritis rheumatoid / Rheumatoid arthritis, unspecified / R arthritis / Rh arthritis / Rheumatoid arthritis NOS / Rheumatoid arthritis NOS (disorder)

Indication	Status	Phase
DBCOND0027961 (Rheumatoid Arthritis)	Terminated	2

clinicaltrials.gov Identifier	Title	Purpose	Drugs
NCT00941707	An Efficacy and Safety Study of JNJ-38518168 in Adult Participants With Rheumatoid Arthritis	Treatment	Toreforant (DB12522)
NCT01679951	A Dose Range Finding Study of JNJ-38518168 in Patients With Active Rheumatoid Arthritis in Spite of Treatment With Methotrexate	Treatment	Methotrexate (DB00563) Toreforant (DB12522)
NCT01862224	A Synovial Biopsy Study of JNJ-38518168 in Participants With Active Rheumatoid Arthritis Despite Methotrexate Therapy	Treatment	Methotrexate (DB00563) Toreforant (DB12522)